Skip to content

Effectiveness of Non-surgical Management in Rotator Cuff Calcific Tendinopathy (THE EFFECT TRIAL)

Effectiveness of Non-surgical Management in Rotator Cuff Calcific Tendinopathy: a Randomised Clinical Trial (THE EFFECT TRIAL)

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05478902
Acronym
EFFECT
Enrollment
116
Registered
2022-07-28
Start date
2028-01-01
Completion date
2029-12-01
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcification Tendon, Calcific Shoulder Tendinitis, Calcific Tendinitis, Rotator Cuff Injuries, Rotator Cuff Tendinosis, Shoulder Pain, Shoulder Tendinitis

Keywords

exercise therapy, lavage, rotator cuff calcific tendinopathy, shoulder calcification, extracorporeal shockwave therapy, ultrasound-guided percutaneous irrigation, shoulder pain, shape up my shoulders, sums

Brief summary

The aim of this study will be to compare the effectiveness of an exercise therapy program with extracorporeal shockwave therapy, ultrasound-guided percutaneous irrigation and a wait and see approach in people with rotator cuff calcific tendinopathy.

Detailed description

Rotator cuff calcific tendinopathy (RCCT) is a common musculoskeletal disorder caused by the presence of calcific deposits in the rotator cuff with an important impact in the quality of life of those who are suffering it. Conservative interventions such as extracorporeal shockwave therapy (ESWT) or ultrasound-guided percutaneous irrigation of calcific tendinopathy (US-PICT) have been commonly recommended as part of the early management for this clinical condition. Exercise therapy (ET) has shown to be an effective intervention for people with rotator cuff tendinopathy, but it has not been tested in people with RCCT yet. A randomised, single-blinded four parallel group clinical trial will be conducted. Participants (n=116) will be randomised in four groups: (1) ET; (2) ESWT; (3) US-PICT or (4) control.

Interventions

PROCEDUREExercise Therapy

Exercise protocol for rotator cuff related shoulder pain

PROCEDUREExtracorporeal Shockwave Therapy

High Energy Extracorporeal Shockwave Therapy

PROCEDUREUltrasound-Guided Percutaneous Irrigation

Two sessions of Ultrasound-Guided Percutaneous Irrigation

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* calcification deposit in the rotator cuff confirmed by diagnostic imaging (ultrasound, MRI or X-ray); * pain and loss of function in the shoulder; * not currently receiving physiotherapy or ESWT.

Exclusion criteria

* previous treatments on last year (e.g., injections, ESWT, US-PICT, surgery, etc.); * other shoulder disorders or trauma (e.g., fractures, dislocations, rotator cuff tears, frozen shoulder or shoulder instability); * known allergy to any of the pharmacological products used in the study; * taking oral anticoagulants * taking oral steroid within the six months prior to participation in the study; * cancer, systemic disease, pregnancy or infection; * neck pain.

Design outcomes

Primary

MeasureTime frameDescription
Shoulder Pain And Disability Index (SPADI)BaselinePain and function shoulder scale. Patients are told to circle the number that best describes their pain where: 0 = no pain and 10 = the worst pain imaginable. The means of the two subscales are averaged to produce a total score ranging from 0 (best) to 100 (worst).

Secondary

MeasureTime frameDescription
Pain IntensityBaselineShoulder pain intensity reported by the patient will be assessed using a 100-mm visual analogue scale (VAS, 0-100, 0=minimum score, 100=maximum score). Higher values represent a better outcome (less pain). Flexion, abduction, external rotation and hand behind the back
Range of motionBaselineFlexion, abduction and hand behind the back measured with a questionnaire with different stages. Degrees measured in different stages ranged from 0-30º, 30-60º, 60-90º, 90-120º, 120-150º and above 150º for flexion and abduction. For hand behind the back: hand to the hip, to the buttock, low back, mid back or between scapulas.
Type of calcificationBaselineaccording to the Gartner classification assessed with x-ray by an experienced radiologist
Size of the calcificationBaselineMeasured in millimeters. Assessed with X-ray by an experienced radiologist
Location of the calcificationBaselineWhich tendon is affected. Assessed with X-ray by an experienced radiologist
Morphology of the calcificationBaselineIsolated- fragmented - multiple. Assessed with X-ray by an experienced radiologist
Central Sensitization Inventory (CSI)BaselinePatient-reported instrument to identify when patient's symptoms may be related to central sensitization
Pittsburgh Sleep Quality Index (PSQI)BaselineSelf-reported questionnaire for measuring the subjective perception of sleep quality
Fear Avoidance Beliefs Questionnaire (FABQ)BaselinePatient-reported instrument for measuring fear avoidance and beliefs. The score range is 0 to 96, with a higher value reflecting a higher degree of fear avoidance beliefs.
Tampa Scale for Kinesiophobia (TSK)BaselineSelf-reported questionnaire for measuring fear of movement or fear of (re)injury
painDETECT ScaleBaselineSelf-administered questionnaire, developed to quickly detect neuropathic pain, asking the patient about the pain experienced at the moment and with- in the last 4 weeks
Pain Catastrophizing ScaleBaselinePatient-reported outcome to measure catastrophization
EuroQoL-5DBaselinePatient-reported outcome to measure quality of life
Hospital Anxiety and Depression ScaleBaselinePatient-reported outcome to measure psychological factors
Patient Satisfaction2 weeksGlobal impression of change
Night PainBaselineHow much has the pain affected the patient at night in the last 4 weeks. From 1 to 5. 5 means worst. 1: No pain. 2: Pain 1 or 2 nights in the last 4 weeks. 3: 1 or 2 nights a week. 4: Pain almost every night. 5: Pain every night.

Countries

Spain

Contacts

STUDY_DIRECTOREnrique Lluch, PT, PhD

University of Valencia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026